Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.60 |
| ▸ | EGFR | P00533 | 3/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | EHMT2 | Q96KQ7 | 7/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.46 |
| ▸ | TERT | O14746 | 3/20 | 0.45 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RAF1 | P04049 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13434518 | 0.89 | MAPT (0.52) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL3418821 | 0.83 | TERT (0.61) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL13434540 | 0.81 | TERT (0.57) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL3418386 | 0.80 | MAPT (0.90) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL3418752 | 0.79 | MAPT (0.63) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL31218585 | 0.79 | MAPT (0.63) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL3416154 | 0.79 | TERT (0.62) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL13434544 | 0.78 | SMN1; SMN2 (0.59) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL14882640 | 0.78 | TERT (0.56) | MAPTEGFRMAPK1KMT2ALMNA | |
| SCHEMBL3415549 | 0.76 | NSD2 (0.62) | MAPTEGFRMAPK1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9334281-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334281-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334281-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-8715944-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8715944-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8715944-B2 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-20100062429-A1 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
| US-20100062429-A1 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
| US-20100062429-A1 | Fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
| WO-2010028349-A2 | FLUOROCHROMES FOR ORGANELLE TRACING AND MULTI-COLOR IMAGING | ENZO LIFE SCIENCES, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010028349-A2 | FLUOROCHROMES FOR ORGANELLE TRACING AND MULTI-COLOR IMAGING | ENZO LIFE SCIENCES, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100062460-A1 | Novel fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
| US-20100062460-A1 | Novel fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
| US-20100062460-A1 | Novel fluorochromes for organelle tracing and multi-color imaging | ENZO LIFE SCIENCES, INC. | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100062429-A1 | Fluorochromes for organelle tracing and multi-color imaging | MFN2, TFEB, NDC1 | MAPT 469/4885EGFR 4732/4885MAPK1 2481/4885 |
| US-20100062460-A1 | Novel fluorochromes for organelle tracing and multi-color imaging | MFN2, TFEB, NUMA1 | MAPT 574/4885EGFR 4790/4885MAPK1 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.